AXON
Price
$590.40
Change
+$13.50 (+2.34%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
45.98B
18 days until earnings call
XLO
Price
$0.84
Change
+$0.05 (+6.33%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
41.42M
13 days until earnings call
Ad is loading...

AXON vs XLO

Header iconAXON vs XLO Comparison
Open Charts AXON vs XLOBanner chart's image
Axon Enterprise
Price$590.40
Change+$13.50 (+2.34%)
Volume$5.35K
Capitalization45.98B
Xilio Therapeutics
Price$0.84
Change+$0.05 (+6.33%)
Volume$6.5K
Capitalization41.42M
AXON vs XLO Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. XLO commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a StrongBuy and XLO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (AXON: $576.76 vs. XLO: $0.80)
Brand notoriety: AXON and XLO are both not notable
AXON represents the Aerospace & Defense, while XLO is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 52% vs. XLO: 11%
Market capitalization -- AXON: $45.98B vs. XLO: $41.42M
AXON [@Aerospace & Defense] is valued at $45.98B. XLO’s [@Biotechnology] market capitalization is $41.42M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $210.52B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $16.79B. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileXLO’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • XLO’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than XLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 6 TA indicator(s) are bullish while XLO’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 6 bullish, 2 bearish.
  • XLO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AXON is a better buy in the short-term than XLO.

Price Growth

AXON (@Aerospace & Defense) experienced а +0.86% price change this week, while XLO (@Biotechnology) price change was +5.55% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was +1.47%. For the same industry, the average monthly price growth was -1.74%, and the average quarterly price growth was +16.07%.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

AXON is expected to report earnings on Aug 12, 2025.

XLO is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Aerospace & Defense (+1.47% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($46B) has a higher market cap than XLO($41.4M). AXON YTD gains are higher at: -2.955 vs. XLO (-16.230). AXON has higher annual earnings (EBITDA): 437M vs. XLO (-58M). AXON has more cash in the bank: 986M vs. XLO (55.3M). XLO has less debt than AXON: XLO (8.14M) vs AXON (722M). AXON has higher revenues than XLO: AXON (2.08B) vs XLO (6.34M).
AXONXLOAXON / XLO
Capitalization46B41.4M111,111%
EBITDA437M-58M-753%
Gain YTD-2.955-16.23018%
P/E Ratio123.06N/A-
Revenue2.08B6.34M32,834%
Total Cash986M55.3M1,783%
Total Debt722M8.14M8,868%
FUNDAMENTALS RATINGS
AXON: Fundamental Ratings
AXON
OUTLOOK RATING
1..100
22
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
11
SMR RATING
1..100
47
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
54
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AXONXLO
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACU42.401.51
+3.69%
Acme United Corp
CSCI3.110.07
+2.47%
COSCIENS Biopharma Inc
NWE58.40-0.38
-0.65%
NorthWestern Energy Group
IMXI12.26-0.11
-0.89%
International Money Express
LII508.76-50.17
-8.98%
Lennox International

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
+3.82%
TECH - AXON
61%
Loosely correlated
+2.20%
VCYT - AXON
58%
Loosely correlated
+1.08%
BEAM - AXON
57%
Loosely correlated
+3.87%
SEER - AXON
56%
Loosely correlated
-2.39%
ADPT - AXON
56%
Loosely correlated
+4.99%
More

XLO and

Correlation & Price change

A.I.dvisor tells us that XLO and CRMD have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XLO and CRMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XLO
1D Price
Change %
XLO100%
-1.23%
CRMD - XLO
31%
Poorly correlated
-0.65%
AXON - XLO
31%
Poorly correlated
+3.82%
VKTX - XLO
30%
Poorly correlated
+1.22%
VTGN - XLO
27%
Poorly correlated
+5.85%
AVTX - XLO
27%
Poorly correlated
+1.64%
More